• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于测定血浆和细胞裂解物中凝血因子 XIII A 亚基的酶联免疫吸附测定法。

Enzyme-linked immunosorbent assay for the determination of blood coagulation factor XIII A-subunit in plasma and in cell lysates.

作者信息

Katona E E, Ajzner E, Tóth K, Kárpáti L, Muszbek L

机构信息

Department of Clinical Biochemistry and Molecular Pathology, Medical and Health Science Centre, University of Debrecen, P.O. Box 40, H-4012, Debrecen, Hungary.

出版信息

J Immunol Methods. 2001 Dec 1;258(1-2):127-35. doi: 10.1016/s0022-1759(01)00479-3.

DOI:10.1016/s0022-1759(01)00479-3
PMID:11684129
Abstract

A new one-step ELISA was developed for the determination of the concentration of blood coagulation factor XIII subunit A (FXIII-A) in plasma and in cell lysates. Monoclonal antibodies directed against different epitopes on FXIII-A were used for the assay. The capture antibody was biotinylated on its carbohydrate moiety and the detection antibody was labelled with horseradish peroxidase. The antigen-antibody reaction was carried out in the well of a streptavidin-coated microplate. Complex formation with FXIII subunit B (FXIII-B) and association to fibrinogen did not influence the accessibility of the antibodies to FXIII-A. The method could be performed within 2 h and demonstrated good reproducibility, recovery and sensitivity. Plasma samples could be assayed after storage at -20 degrees C for at least 6 months. However, in the case of platelet lysates freezing and rethawing resulted in a significant loss of FXIII-A. FXIII-A concentrations measured in the plasma samples of healthy individuals and patients correlated well with the concentrations of complexed plasma FXIII (A2B2) and with the results of FXIII activity measurements. A reference range of 46-82 fg/platelet was established for platelet FXIII-A.

摘要

开发了一种新的一步酶联免疫吸附测定法(ELISA),用于测定血浆和细胞裂解物中凝血因子 XIII 亚基 A(FXIII-A)的浓度。针对 FXIII-A 不同表位的单克隆抗体用于该测定。捕获抗体在其碳水化合物部分进行了生物素化,检测抗体用辣根过氧化物酶标记。抗原 - 抗体反应在链霉亲和素包被的微孔板孔中进行。与 FXIII 亚基 B(FXIII-B)形成复合物以及与纤维蛋白原结合并不影响抗体与 FXIII-A 的结合。该方法可在 2 小时内完成,具有良好的重现性、回收率和灵敏度。血浆样本在 -20℃储存至少 6 个月后仍可进行测定。然而,对于血小板裂解物,冷冻和解冻会导致 FXIII-A 显著损失。在健康个体和患者的血浆样本中测得的 FXIII-A 浓度与复合血浆 FXIII(A2B2)的浓度以及 FXIII 活性测量结果相关性良好。为血小板 FXIII-A 建立了 46 - 82 fg/血小板的参考范围。

相似文献

1
Enzyme-linked immunosorbent assay for the determination of blood coagulation factor XIII A-subunit in plasma and in cell lysates.用于测定血浆和细胞裂解物中凝血因子 XIII A 亚基的酶联免疫吸附测定法。
J Immunol Methods. 2001 Dec 1;258(1-2):127-35. doi: 10.1016/s0022-1759(01)00479-3.
2
A simple, quick one-step ELISA assay for the determination of complex plasma factor XIII (A2B2).一种用于测定血浆中复杂的凝血因子 XIII(A2B2)的简单、快速的一步酶联免疫吸附测定法。
Thromb Haemost. 2000 Feb;83(2):268-73.
3
Assessment of Factor XIII.凝血因子 XIII 的评估
Methods Mol Biol. 2017;1646:277-293. doi: 10.1007/978-1-4939-7196-1_22.
4
Severe bleeding complications caused by an autoantibody against the B subunit of plasma factor XIII: a novel form of acquired factor XIII deficiency.一种针对血浆因子 XIII B 亚基的自身抗体引起的严重出血并发症:一种新型获得性因子 XIII 缺乏症。
Blood. 2009 Jan 15;113(3):723-5. doi: 10.1182/blood-2008-09-179333. Epub 2008 Oct 27.
5
Rapid immunochromatographic test for detection of anti-factor XIII A subunit antibodies can diagnose 90 % of cases with autoimmune haemorrhaphilia XIII/13.用于检测抗凝血因子 XIII A 亚基抗体的快速免疫层析试验可诊断 90% 的自身免疫性血友病 XIII/13 病例。
Thromb Haemost. 2015 Jun;113(6):1347-56. doi: 10.1160/TH14-09-0745. Epub 2015 Mar 5.
6
Development and Epitope Mapping of Seven Mouse Anti-Human Coagulation Factor XIII-B Subunit Monoclonal Antibodies.开发及人凝血因子 XIII-B 亚单位单克隆抗体 7 个表位的绘图。
Monoclon Antib Immunodiagn Immunother. 2024 Oct;43(5):135-143. doi: 10.1089/mab.2024.0016. Epub 2024 Sep 25.
7
Subunit B of factor XIII is present in bovine platelets.
Thromb Res. 1988 Jun 15;50(6):767-74. doi: 10.1016/0049-3848(88)90337-4.
8
Non-autoimmune combined factor XIII A and B subunit deficiencies in rheumatoid arthritis patients treated with anti-interleukin-6 receptor monoclonal antibody (tocilizumab).类风湿关节炎患者接受抗白细胞介素-6 受体单克隆抗体(托珠单抗)治疗后出现非自身免疫性联合因子 XIII A 和 B 亚单位缺乏。
Thromb Res. 2016 Apr;140:100-105. doi: 10.1016/j.thromres.2016.02.026. Epub 2016 Feb 26.
9
Factor XIII activation peptide is released into plasma upon cleavage by thrombin and shows a different structure compared to its bound form.凝血因子 XIII 激活肽在被凝血酶切割后释放到血浆中,与其结合形式相比呈现出不同的结构。
Thromb Haemost. 2007 Jun;97(6):890-8.
10
Interaction of factor XIII subunits.因子 XIII 亚基的相互作用。
Blood. 2014 Mar 13;123(11):1757-63. doi: 10.1182/blood-2013-10-533596. Epub 2014 Jan 9.

引用本文的文献

1
Activated platelets retain and protect most of their factor XIII-A cargo from proteolytic activation and degradation.活化的血小板保留并保护其大部分因子 XIII-A 货物免受蛋白水解激活和降解。
Blood Adv. 2024 Oct 8;8(19):5072-5085. doi: 10.1182/bloodadvances.2024012979.
2
Differential Role of Factor XIII in Acute Myocardial Infarction and Ischemic Stroke.凝血因子 XIII 在急性心肌梗死和缺血性卒中中的不同作用
Biomedicines. 2024 Feb 22;12(3):497. doi: 10.3390/biomedicines12030497.
3
Cellular FXIII in Human Macrophage-Derived Foam Cells.人巨噬细胞源性泡沫细胞中的细胞 FXIII。
Int J Mol Sci. 2023 Mar 2;24(5):4802. doi: 10.3390/ijms24054802.
4
Location, location, location: Fibrin, cells, and fibrinolytic factors in thrombi.位置、位置、位置:血栓中的纤维蛋白、细胞及纤维蛋白溶解因子
Front Cardiovasc Med. 2023 Jan 18;9:1070502. doi: 10.3389/fcvm.2022.1070502. eCollection 2022.
5
Fibrinogen and Factor XIII in Venous Thrombosis and Thrombus Stability.纤维蛋白原和因子 XIII 在静脉血栓形成和血栓稳定性中的作用。
Arterioscler Thromb Vasc Biol. 2022 Aug;42(8):931-941. doi: 10.1161/ATVBAHA.122.317164. Epub 2022 Jun 2.
6
The Effect of Activated FXIII, a Transglutaminase, on Vascular Smooth Muscle Cells.活化型 XIII 因子(转谷氨酰胺酶)对血管平滑肌细胞的影响。
Int J Mol Sci. 2022 May 23;23(10):5845. doi: 10.3390/ijms23105845.
7
Activation mechanism dependent surface exposure of cellular factor XIII on activated platelets and platelet microparticles.激活的血小板和血小板微粒上细胞因子 XIII 依赖激活机制的表面暴露。
J Thromb Haemost. 2022 May;20(5):1223-1235. doi: 10.1111/jth.15668. Epub 2022 Feb 21.
8
Factor XIII-A: An Indispensable "Factor" in Haemostasis and Wound Healing.凝血因子 XIII-A:止血和伤口愈合中不可或缺的“因子”
Int J Mol Sci. 2021 Mar 17;22(6):3055. doi: 10.3390/ijms22063055.
9
Factor XIII and Fibrin Clot Properties in Acute Venous Thromboembolism.急性静脉血栓栓塞症中的因子 XIII 和纤维蛋白凝块特性。
Int J Mol Sci. 2021 Feb 5;22(4):1607. doi: 10.3390/ijms22041607.
10
Exposure of plasminogen and a novel plasminogen receptor, Plg-RKT, on activated human and murine platelets.激活的人源和鼠源血小板表面的纤溶酶原和新型纤溶酶原受体 Plg-RKT 的暴露。
Blood. 2021 Jan 14;137(2):248-257. doi: 10.1182/blood.2020007263.